Bladder & Pelvic FloorEvidence check
Lactin-V for Recurrent UTIs: The 2011 Trial
A trial left prevention uncertain.
Free shipping
ArticlesTopic 01
Leaks when you laugh, sneeze or run, the sudden urge, and the muscles that can change it.
Bladder & Pelvic FloorEvidence check
A trial left prevention uncertain.
Bladder & Pelvic FloorEvidence check
An eight-week trial did not establish added benefit.
Bladder & Pelvic FloorEvidence check
A switching trial missed its main target.
Bladder & Pelvic FloorEvidence check
Urgency and leaking were separate outcomes.
Bladder & Pelvic FloorEvidence check
The overall result differed from the dose subgroup.
Bladder & Pelvic FloorEvidence check
The added reduction in leaks needs a comparison with mirabegron alone.
Bladder & Pelvic FloorEvidence check
Treatment switching matters when interpreting improvement.
Bladder & Pelvic FloorEvidence check
Early recovery and kidney infections favored the antibiotic.
Bladder & Pelvic FloorEvidence check
Compare the dose, leak counts, follow-up population and support each procedure requires.
Bladder & Pelvic FloorEvidence check
A restricted U.S. indication and a combined symptom-and-culture endpoint need careful reading.
Bladder & Pelvic FloorEvidence check
What the application comparison can tell you about preventing repeat UTIs.
Bladder & Pelvic FloorEvidence check
Compare satisfaction, repeat procedures and complications when discussing treatment for stress leaks.